2026 жылында Италияда таралған склероздың емдеу бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

Italy hosts leading neurology centers recognized globally for multiple sclerosis (MS) care. Top-rated facilities include San Raffaele Hospital and San Donato Hospital in Milan. These institutions hold IRCCS accreditation for combining clinical excellence with advanced research. They rank among the best specialized hospitals globally.

• San Raffaele Hospital: Ranked 43rd globally for neurology with elite MS research programs.
• San Donato Hospital: Holds a 4.9 rating and specializes in advanced neurorehabilitation.
• Carlo Besta Institute: Ranked as the top neurology hospital in Italy for complex disorders.
• Gemelli University Policlinic: A premier Rome-based center ranked 29th globally for neurology.

Bookimed Expert Insight: Data shows Milan is the primary hub for MS care. Hospitals like San Raffaele and San Donato serve over 300,000 patients annually. This high volume ensures specialists manage diverse MS cases regularly. Choosing these larger IRCCS centers often provides faster access to the latest disease-modifying therapies. These treatments may reach smaller regional hospitals much later.

Patient Consensus: Patients note that university hospitals in Milan and Rome offer the best specialist access. Many recommend using private consultations to skip long public wait times for initial diagnosis. Traveling from southern regions to northern centers is common to access newer monoclonal antibody treatments.

The latest Disease-Modifying Therapies (DMTs) for multiple sclerosis are available in Italy. The Italian Pharmaceutical Agency (AIFA) authorizes and reimburses high-efficacy treatments. Patients access these therapies through specialized MS centers. Availability includes S1P receptor modulators and monoclonal antibodies like ocrelizumab.

• Available medications: Ocrelizumab, ozanimod, siponimod, and ponesimod are approved for clinical use.
• High-efficacy options: Cladribine tablets and ofatumumab are refundable for highly active relapsing MS.
• Specialized care: Neurologists at IRCCS-accredited centers like San Raffaele manage advanced treatment protocols.
• Research integration: Leading hospitals combine clinical assistance with active research into emerging MS therapies.

Bookimed Expert Insight: Data shows a clear advantage in seeking treatment at IRCCS-accredited facilities in Milan. San Raffaele and San Donato Hospital both maintain this research designation. These institutions often provide faster access to newer protocols. They serve over 300,000 patients annually and integrate the latest research directly into clinical practice.

Patient Consensus: Patients note it is important to document all disease activity to speed up drug approvals. Those in Northern Italy often report shorter waiting times for receiving their first infusions.

International patients can obtain remote second opinions from leading Italian neurological centers specializing in Multiple Sclerosis. Institutions like San Raffaele Research Hospital in Milan provide virtual consultations via secure platforms. Specialists review clinical history, laboratory reports, and MRI scans to confirm diagnoses or suggest treatment adjustments.

• Expert access: Professor Massimo Filippi at San Raffaele provides expert reviews via video sessions.
• Digital platforms: Consultations typically occur through secure channels like Microsoft Teams or Zoom.
• Required records: Patients must upload MRI scans in DICOM format and neurological reports first.
• Written reports: Specialists provide formal documentation outlining findings and recommended next steps.

Bookimed Expert Insight: San Raffaele and San Donato share the same Italian Ministry of Health accreditation. Both facilities manage over 300,000 patients annually using high-volume research protocols. This shared infrastructure ensures that even remote consultations benefit from Europe's largest clinical data pools. Choosing either facility provides access to identical quality standards for complex neuro-immunological reviews.

Patient Consensus: Patients note that uploading high-quality MRI scans in advance is the most critical step. They suggest using translation tools for initial outreach to ensure clinical records are understood correctly.

Italy's National Health Service (SSN) provides free or highly subsidized care for Multiple Sclerosis. Patients access specialized centers for diagnosis and monitoring. Disease-modifying therapies (DMTs) are fully covered. The system includes exemptions for specialist visits and diagnostic tests like MRI scans.

• Specialized network: Over 240 neurology centers manage prescriptions and follow-ups.
• Subsidized medication: First-line and advanced therapies require no out-of-pocket costs.
• Financial support: Patients receive exemptions from co-payments for all MS-related care.
• Disability benefits: Approved patients access free walking aids and monthly allowances.

Bookimed Expert Insight: Quality of care often correlates with research hospital status. Facilities like San Raffaele and San Donato in Milan hold IRCCS accreditation. This status combines clinical care with advanced research activities. Data shows these northern centers often provide faster access to innovative treatments. This includes protocols like hematopoietic stem cell transplantation (HSCT) for aggressive cases.

Patient Consensus: Patients value the zero-cost access to expensive medications compared to other countries. Many note it is important to prepare for bureaucratic delays when applying for disability pensions.

Therapies including haematopoietic stem cell transplantation (AHSCT) are available at specialised Italian centres. These treatments typically target aggressive forms of multiple sclerosis. Italy maintains strict regulatory oversight through the Ministry of Health and IRCCS-accredited research hospitals.

• Specialised centres: San Raffaele in Milan holds IRCCS accreditation for neurology and neurosurgery research.
• Treatment protocols: AHSCT is the established method used for severe cases resistant to medicine.
• Research focus: Centres explore mesenchymal and neural stem cells to help modulate immune responses.
• Hospital standards: Leading facilities like San Donato Hospital serve over 300,000 patients annually.

Bookimed Expert Insight: Italy stands out because its top neurology centres, such as San Raffaele, are IRCCS-certified research hospitals. This means they integrate laboratory breakthroughs directly into clinical practice. Patients often find these academic centres offer earlier access to emerging protocols like Natural Killer cell therapy.

Patient Consensus: Patients in Italy emphasise that options like HSCT require rigorous eligibility checks by specialists. Experience shows that coordinating with local neurologists is essential. This helps manage the extended pre-treatment assessments and follow-up care required.

Italian specialists treat all types of multiple sclerosis. These include relapsing-remitting, secondary progressive, primary progressive, and clinically isolated syndrome. Research hospitals like San Raffaele in Milan use therapies such as Ocrevus and plasmapheresis. They focus on tailored care to manage inflammation and neurological damage.

• Relapsing-remitting MS: This is the most common form treated. Specialists use disease-modifying therapies to manage attacks.
• Progressive MS forms: Specialists manage both primary and secondary progressive types with a focus on rehabilitation.
• Clinically isolated syndrome: Doctors monitor early neurological episodes to determine the risk of progression.
• Specialised therapy options: Major centres provide intensive options like plasmapheresis and specific medication protocols.

Bookimed Expert Insight: Italian research hospitals like San Raffaele and San Donato use their IRCCS accreditation to link clinical trials and patient care. This status allows them to offer customised treatments for rare immune conditions. For Australian patients, this means access to specialised protocols like Natural Killer cell therapy. These are often restricted to research settings elsewhere.

Patient Consensus: Patients find that Italian specialists focus heavily on matching the specific MS phenotype to the treatment. This is particularly true for highly active relapsing disease. They often suggest checking a centre's experience with progressive forms before travelling to Italy.

Italy offers holistic rehabilitation for multiple sclerosis through a network of 240 specialised centres. These facilities integrate neurological care with physiotherapy, psychological support, and occupational therapy. Accredited IRCCS hospitals in Milan and Rome provide research-led protocols. These programs aim to improve daily function and mobility.

• Integrated care: Teams include neurologists, psychologists, and rehabilitation specialists for physical and mental health.
• Diagnostic tools: Centres use brain MRI with contrast and visual evoked potentials (VEP-test) for staging.
• Specialised networks: San Donato Hospital and Ospedale San Raffaele hold Italian Ministry of Health accreditation.
• Therapeutic options: Programs involve medication, plasmapheresis, and targeted rehabilitation to manage specific MS symptoms.

Bookimed Expert Insight: Italian healthcare uses a strict IRCCS accreditation for research hospitals. Ospedale San Raffaele and San Donato Hospital both hold this status. This means they combine clinical treatment with active scientific research. Patients benefit from earlier access to emerging therapies before they reach standard clinics.

Patient Consensus: Patients note that Italian care focuses heavily on neurological expertise within major accredited hospitals. It is important to treat holistic services as complementary to evidence-based medical treatments.

International patients seeking multiple sclerosis treatment in Italy undergo a structured clinical process. It begins with a remote neurological assessment. Patients submit MRI scans and medical records to centres like San Raffaele in Milan. Local specialists confirm the diagnosis before creating a tailored treatment plan.

• Record submission: Patients provide MRI scans on disc and cerebrospinal fluid results.
• Specialist consultation: Neurologists at IRCCS-accredited hospitals evaluate disease progression and subtype.
• Diagnostic baseline: Clinics often repeat contrast MRIs and blood tests on-site.
• Therapeutic implementation: Treatment includes disease-modifying therapies, plasmapheresis, or specialised neuro-rehabilitation.

Bookimed Expert Insight: Italian research hospitals like San Raffaele and San Donato combine clinical care with active research. They manage over 300,000 patients annually. This high volume allows doctors to develop protocols for rare immune responses. For Australian patients, this means access to specialists who handle complex, treatment-resistant cases daily.

Patient Consensus: Patients note it is essential to bring a complete medication history and radiology reports. Italian centres prioritise a records-heavy intake for treatment continuity once patients return home.